Arrowstreet Capital Limited Partnership Sells 551,791 Shares of Nutrien Ltd. $NTR

Arrowstreet Capital Limited Partnership reduced its position in Nutrien Ltd. (NYSE:NTRFree Report) by 3.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 13,669,590 shares of the company’s stock after selling 551,791 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Nutrien were worth $843,726,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Montag A & Associates Inc. raised its holdings in shares of Nutrien by 310.7% in the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after acquiring an additional 320 shares in the last quarter. Sfam LLC bought a new stake in shares of Nutrien in the fourth quarter valued at about $37,000. Eastern Bank raised its holdings in shares of Nutrien by 133.0% in the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after acquiring an additional 399 shares in the last quarter. Harbour Investments Inc. raised its holdings in shares of Nutrien by 97.2% in the fourth quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock valued at $43,000 after acquiring an additional 347 shares in the last quarter. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Nutrien by 42.4% in the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock valued at $43,000 after acquiring an additional 219 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Stock Performance

Shares of Nutrien stock opened at $67.65 on Friday. The company has a market capitalization of $32.47 billion, a PE ratio of 13.78, a P/E/G ratio of 0.62 and a beta of 0.60. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24. The company has a 50-day simple moving average of $71.34 and a two-hundred day simple moving average of $69.17. Nutrien Ltd. has a one year low of $53.03 and a one year high of $85.36.

Nutrien (NYSE:NTRGet Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The firm’s revenue was up 18.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.11 earnings per share. Research analysts expect that Nutrien Ltd. will post 5.45 EPS for the current fiscal year.

Nutrien Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a yield of 3.3%. Nutrien’s payout ratio is currently 44.81%.

Analyst Ratings Changes

NTR has been the subject of several recent research reports. UBS Group decreased their price objective on Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a report on Monday, May 11th. Scotiabank lifted their price objective on Nutrien from $75.00 to $80.00 and gave the company a “sector perform” rating in a report on Monday, May 11th. JPMorgan Chase & Co. lifted their price objective on Nutrien from $78.00 to $80.00 and gave the company an “overweight” rating in a report on Monday, May 11th. BNP Paribas Exane downgraded shares of Nutrien from an “outperform” rating to a “neutral” rating in a report on Monday, February 23rd. Finally, Raymond James Financial upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $74.00 to $90.00 in a report on Tuesday, May 5th. Eleven investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $81.71.

Check Out Our Latest Analysis on Nutrien

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Articles

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.